Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 134

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 134
---
 requested by
NLS Pharmaceutics Ltd., a corporation incorporated in Switzerland (the “Company”), and have represented the Company
in connection with that certain Securities Purchase Agreement, dated as of March 26, 2025 (the “Securities Purchase Agreement”),
entered into by and among the Company and the purchasers named therein (collectively, the “Holders”) pursuant to which
the Company issued to the Holders convertible Preferred Shares (“Preferred Shares”) convertible for shares of the
Company's ordinary shares, par value CHF0.03 per share (the “Common Shares”) (the Common Shares issuable pursuant
to the terms of the Preferred Shares and Securities Purchase Agreement, collectively, the “Conversion Shares”) and
warrants exercisable for shares of Common Shares (the “Warrants”). Pursuant to the Securities Purchase Agreement,
the Company also has entered into a Registration Rights Agreement with the Holders (the “Registration Rights Agreement”)
pursuant to which the Company agreed, among other things, to register the resale of the Registrable Securities (as defined in the Registration
Rights Agreement), including the Common Shares issuable pursuant to the Securities Purchase Agreement and Common Shares issuable upon
exercise of the Warrants under the Securities Act of 1933, as amended (the “1933 Act”). The description of the Registrable
Securities are set forth on Schedule A hereto [Selling Shareholder Table]. In connection with the Company's obligations under
the Registration Rights Agreement, on March 26, 2025, the Company filed a Registration Statement on Form [RC] (File No. _____________)
(the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating
to the Registrable Securities which names each of the Holders as a selling shareholder thereunder.

In connection with the foregoing,
we advise you that a member of the SEC's staff has advised us by telephone that the SEC has entered an order declaring the Registration
Statement effective under the 1933 Act at [ENTER TIME OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS].
We have no knowledge, subsequent to such telephonic conversation with the SEC's staff, that any stop order suspending its effectiveness
has been issued or that any proceedings for that purpose are pending before, or threatened by, the SEC. Based on the foregoing, the Registrable
Securities set forth on Schedule A hereto are available for resale under the 1933 Act pursuant to the Registration Statement.

This